Bevacizumab with delayed laser offers good refractive outcomes in ROP

Researchers compared refractive outcomes of primary peripheral retinal photocoagulation versus bevacizumab with delayed PRP in infants with posterior type 1 retinopathy of prematurity.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553